Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 7.00 Billion |
| USD 58.16 Billion | |
| % | |
|
Global Artificial Intelligence (AI) Based Critical Care Market, By Offering (Hardware, Software, Services), Technology (Machine Learning, Context-Aware Computing, Natural Language Processing, Computer Vision, Speech Recognition, Querying Method), Application (Health Monitoring, Digital Consultation, Virtual Nurses, Precision Medicine, Drug Creation, Healthcare System Analysis, Medication Management, Others) – Industry Trends and Forecast to 2029.
The artificial intelligence (AI) based critical care market is expected to witness significant growth during the forecast period. In the healthcare industry, artificial intelligence is utilized to investigate the relationship between therapeutic approaches and patient outcomes. AI in healthcare has numerous uses in drug research, treatment regimens, and medication administration. It is employed in medical procedures like diagnosis, tailored medication, drug development, and patient care monitoring. The demand for AI in healthcare is primarily driven by the growth of the market for artificial intelligence in healthcare and the complexity of datasets and their volume.
Data Bridge Market Research analyses a growth rate in the artificial intelligence (AI) based critical care market in the forecast period 2022-2029. The expected CAGR of artificial intelligence (AI) based critical care market is tend to be around 30.30% in the mentioned forecast period. The market was valued at USD 7.0 billion in 2021, and it would grow upto USD 58.16 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Artificial intelligence is defined as an intelligent system that uses numerous human intelligence-based functions in fields including biology, computer science, mathematics, linguistics, psychology, and engineering. These functions include reasoning, learning, and problem-solving abilities. Artificial intelligence in the healthcare industry uses algorithms and software to assess intricate medical data.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Offering (Hardware, Software, Services), Technology (Machine Learning, Context-Aware Computing, Natural Language Processing, Computer Vision, Speech Recognition, Querying Method), Application (Health Monitoring, Digital Consultation, Virtual Nurses, Precision Medicine, Drug Creation, Healthcare System Analysis, Medication Management, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Nvidia Corporation (U.S.), IBM (U.S.), AiCure (U.S.), iCarbonX (China), Cyrcadia Health Inc. (U.S.), Atomwise, Inc. (U.S.), Pathway (U.S.)., SOPHiA GENETICS (Switzerland), Apixio, Inc. (U.S.), General Vision, Inc.(U.S.), Microsoft (U.S.), Intel Corporation (U.S.), DeepMind Technologies Limited (U.K.)
|
|
Market Opportunities
|
|
Drivers
The emergence of advanced hardware systems that help improve the efficiency and effectiveness of AI software is expected to drive market growth in the hardware segment. For instance, in 2016 Nvidia improved the efficiency of deep learning and introduced GPUs that are 20 to 50 times more efficient than CPUs.
Government-backed initiatives, increased investment from private investors and venture capitalists, and the emergence of AI-focused start-ups around the world are driving market growth.
Opportunities
AI-based technology has seen significant growth in acceptance and dramatic growth. As the newest developments increases, the need for these AI based techniques increases. For instance, in August 2017, Penn Medicine developed a predictive solution using machine learning. In this solution, the system helps the system analyze a person's vital signs, predict the risk of sepsis, and identify the possibility of heart failure.
AI-based technology in clinical trials is rapidly gaining adoption. It is expected to boost market growth by reducing the time it takes to conduct clinical trials and improving the accuracy and reliability of clinical trials. This is expected to boost the chromatin immunoprecipitation sequencing market during the forecast period.
Restraints/Challenges
The lack of qualified personnel who are unable to use these AI techniques could curb the growth of the global AI based critical care market over a forecast period.
High cost of these techniques can hinder the growth of the global AI based critical care market even though the prevalence of the diseases are high.
This artificial intelligence (AI) based critical care market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial intelligence (AI) based critical care market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.
The adoption of AI technologies is being driven by the growing need for healthcare providers, the need to reduce the rising costs of healthcare, the demand for value-based care, and the growing need to accurately and quickly diagnose and detect underlying health conditions in order to provide the best treatment plan as soon as possible.
The artificial intelligence (AI) based critical care market is segmented on the basis of offering, technology, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Offering
Technology
Application
The artificial intelligence (AI) based critical care market is analysed and market size insights and trends are provided by offering, technology, and application as referenced above.
The major countries covered in the artificial intelligence (AI) based critical care market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is the dominating market due to to advancements in healthcare IT infrastructure, growing care expenditures, widespread adoption of technologies, favorable government initiatives, and presence of several major market players.
Asia-Pacific expected to witness growth due to the rapid innovations and development in the IT infrastructure and entrepreneurship ventures specializing in AI-based technologies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The artificial intelligence (AI) based critical care market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to artificial intelligence (AI) based critical care market
Key players operating in the artificial intelligence (AI) based critical care market include:
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 SALES VOLUME
2.2.11 EPIDEMIOLOGY MODELLING
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTAL ANALYSIS
5.2 PORTER’S FIVE FORCES
5.3 KEY STRATEGIC INITIATIVES
6 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY OFFERING
6.1 OVERVIEW
6.2 HARDWARE
6.2.1 VENTILATORS
6.2.1.1. MARKET VALUE (USD MILLION)
6.2.1.2. MARKET VOLUME (UNITS)
6.2.1.3. AVERAGE SELLING PRICE (USD)
6.2.2 DRUG MANAGEMENT SYSTEM
6.2.2.1. MARKET VALUE (USD MILLION)
6.2.2.2. MARKET VOLUME (UNITS)
6.2.2.3. AVERAGE SELLING PRICE (USD)
6.2.3 VITAL MONITORING SYSTEM
6.2.3.1. MARKET VALUE (USD MILLION)
6.2.3.2. MARKET VOLUME (UNITS)
6.2.3.3. AVERAGE SELLING PRICE (USD)
6.2.4 INFUSION PUMPS
6.2.4.1. MARKET VALUE (USD MILLION)
6.2.4.2. MARKET VOLUME (UNITS)
6.2.4.3. AVERAGE SELLING PRICE (USD)
6.2.5 ECG DEVICES
6.2.5.1. MARKET VALUE (USD MILLION)
6.2.5.2. MARKET VOLUME (UNITS)
6.2.5.3. AVERAGE SELLING PRICE (USD)
6.2.6 OTHERS
6.3 SOFTWARE
6.3.1 DATA AGGREGATION
6.3.2 DATA INTEGRATION
6.3.3 DATA ANALYTICS
6.3.3.1. DATA COLLECTION
6.3.3.2. DATA ACCESS
6.3.3.3. DATA WAREHOUSING
6.3.3.4. DATA MINING
6.3.4 DATA VISUALIZATION
6.3.5 OTHERS
6.4 SERVICES
6.4.1 BY SERVICE TYPE
6.4.1.1. TELE-CONSULATATION
6.4.1.1.1. CENTRALIZED TELE-ICU
6.4.1.1.2. DECENTRALIZED TELE-ICUHYBRID TELE-ICU
6.4.1.2. CRITICAL-CARE NURSING
6.4.1.3. HEALTH ATTENDANT
6.4.1.4. PATIENT VITAL MONITORING SUPPORT
6.4.1.5. OTHERS
6.4.2 BY DISEASE TYPE
6.4.2.1. NEUROLOGY
6.4.2.2. CANCER (INCLUDING PALLIATIVE CARE)
6.4.2.3. PULMONOLOGY
6.4.2.4. CARDIAC
6.4.2.5. NEPHROLOGY
6.4.2.6. OTHERS
6.5 OTHERS
7 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 MACHINE LEARNING
7.3 CONTEXT-AWARE COMPUTING
7.4 NATURAL LANGUAGE PROCESSING
7.5 COMPUTER VISION
7.6 SPEECH RECOGNITION
7.7 QUERYING METHOD
8 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 HEALTH MONITORING
8.2.1 HARDWARE
8.2.2 SOFTWARE
8.2.3 SERVICES
8.3 DIGITAL CONSULTATION
8.3.1 HARDWARE
8.3.2 SOFTWARE
8.3.3 SERVICES
8.4 VIRTUAL NURSES
8.4.1 HARDWARE
8.4.2 SOFTWARE
8.4.3 SERVICES
8.5 PRECISION MEDICINE
8.5.1 HARDWARE
8.5.2 SOFTWARE
8.5.3 SERVICES
8.6 DRUG CREATION
8.6.1 HARDWARE
8.6.2 SOFTWARE
8.6.3 SERVICES
8.7 HEALTHCARE SYSTEM ANALYSIS
8.7.1 HARDWARE
8.7.2 SOFTWARE
8.7.3 SERVICES
8.8 MEDICATION MANAGEMENT
8.8.1 HARDWARE
8.8.2 SOFTWARE
8.8.3 SERVICES
8.9 OTHERS
9 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 AMBULATORY SURGICAL CENTERS
9.4 SPECIALTY CLINICS
9.5 OTHERS
10 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDER
10.3 THIRD PARTY DISTRIBUTORS
10.4 OTHERS
11 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY REGION
GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.1.1. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY OFFERING
11.1.1.2. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY TECHNOLOGY
11.1.1.3. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY APPLICATION
11.1.1.4. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY END USER
11.1.1.5. U.S. ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, BY DISTRIBUTION CHANNEL
11.1.2 CANADA
11.1.3 MEXICO
11.2 EUROPE
11.2.1 GERMANY
11.2.2 FRANCE
11.2.3 U.K.
11.2.4 ITALY
11.2.5 SPAIN
11.2.6 RUSSIA
11.2.7 TURKEY
11.2.8 BELGIUM
11.2.9 DENMARK
11.2.10 NETHERLANDS
11.2.11 SWITZERLAND
11.2.12 SWEDEN
11.2.13 POLAND
11.2.14 NORWAY
11.2.15 FINLAND
11.2.16 REST OF EUROPE
11.3 ASIA-PACIFIC
11.3.1 JAPAN
11.3.2 CHINA
11.3.3 SOUTH KOREA
11.3.4 INDIA
11.3.5 AUSTRALIA
11.3.6 NEW ZEALAND
11.3.7 SINGAPORE
11.3.8 THAILAND
11.3.9 MALAYSIA
11.3.10 VIETNAM
11.3.11 TAIWAN
11.3.12 INDONESIA
11.3.13 PHILIPPINES
11.3.14 REST OF ASIA-PACIFIC
11.4 SOUTH AMERICA
11.4.1 BRAZIL
11.4.2 ARGENTINA
11.4.3 REST OF SOUTH AMERICA
11.5 MIDDLE EAST AND AFRICA
11.5.1 SOUTH AFRICA
11.5.2 SAUDI ARABIA
11.5.3 BAHRAIN
11.5.4 UAE
11.5.5 KUWAIT
11.5.6 OMAN
11.5.7 QATAR
11.5.8 EGYPT
11.5.9 ISRAEL
11.5.10 REST OF MIDDLE EAST AND AFRICA
11.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, SWOT AND DBMR ANALYSIS
13 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13.5 MERGERS & ACQUISITIONS
13.6 NEW PRODUCT DEVELOPMENT & APPROVALS
13.7 EXPANSIONS
13.8 REGULATORY CHANGES
13.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
14 GLOBAL ARTIFICIAL INTELLIGENCE (AI) BASED CRITICAL CARE MARKET, COMPANY PROFILE
14.1 AUTONOMOUS HEALTHCARE
14.1.1 COMPANY OVERVIEW
14.1.2 REVENUE ANALYSIS
14.1.3 GEOGRAPHIC PRESENCE
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 TORADEX SYSTEMS (INDIA) PVT. LTD.
14.2.1 COMPANY OVERVIEW
14.2.2 REVENUE ANALYSIS
14.2.3 GEOGRAPHIC PRESENCE
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 BAXTER
14.3.1 COMPANY OVERVIEW
14.3.2 REVENUE ANALYSIS
14.3.3 GEOGRAPHIC PRESENCE
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 WELLUE
14.4.1 COMPANY OVERVIEW
14.4.2 REVENUE ANALYSIS
14.4.3 GEOGRAPHIC PRESENCE
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 ANUMANA, INC.
14.5.1 COMPANY OVERVIEW
14.5.2 REVENUE ANALYSIS
14.5.3 GEOGRAPHIC PRESENCE
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 XORESEARCH
14.6.1 COMPANY OVERVIEW
14.6.2 REVENUE ANALYSIS
14.6.3 GEOGRAPHIC PRESENCE
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT DEVELOPMENTS
14.7 ALIVECOR, INC.
14.7.1 COMPANY OVERVIEW
14.7.2 REVENUE ANALYSIS
14.7.3 GEOGRAPHIC PRESENCE
14.7.4 PRODUCT PORTFOLIO
14.7.5 RECENT DEVELOPMENTS
14.8 LEPU MEDICAL
14.8.1 COMPANY OVERVIEW
14.8.2 REVENUE ANALYSIS
14.8.3 GEOGRAPHIC PRESENCE
14.8.4 PRODUCT PORTFOLIO
14.8.5 RECENT DEVELOPMENTS
14.9 ETIOMETRY, INC.
14.9.1 COMPANY OVERVIEW
14.9.2 REVENUE ANALYSIS
14.9.3 GEOGRAPHIC PRESENCE
14.9.4 PRODUCT PORTFOLIO
14.9.5 RECENT DEVELOPMENTS
14.1 NETEERA
14.10.1 COMPANY OVERVIEW
14.10.2 REVENUE ANALYSIS
14.10.3 GEOGRAPHIC PRESENCE
14.10.4 PRODUCT PORTFOLIO
14.10.5 RECENT DEVELOPMENTS
14.11 VITLS
14.11.1 COMPANY OVERVIEW
14.11.2 REVENUE ANALYSIS
14.11.3 GEOGRAPHIC PRESENCE
14.11.4 PRODUCT PORTFOLIO
14.11.5 RECENT DEVELOPMENTS
14.12 APOLLO TELEHEALTH
14.12.1 COMPANY OVERVIEW
14.12.2 REVENUE ANALYSIS
14.12.3 GEOGRAPHIC PRESENCE
14.12.4 PRODUCT PORTFOLIO
14.12.5 RECENT DEVELOPMENTS
14.13 EAGLE TELEMEDICINE
14.13.1 COMPANY OVERVIEW
14.13.2 REVENUE ANALYSIS
14.13.3 GEOGRAPHIC PRESENCE
14.13.4 PRODUCT PORTFOLIO
14.13.5 RECENT DEVELOPMENTS
14.14 GE HEALTHCARE
14.14.1 COMPANY OVERVIEW
14.14.2 REVENUE ANALYSIS
14.14.3 GEOGRAPHIC PRESENCE
14.14.4 PRODUCT PORTFOLIO
14.14.5 RECENT DEVELOPMENTS
14.15 HICUITY HEALTH
14.15.1 COMPANY OVERVIEW
14.15.2 REVENUE ANALYSIS
14.15.3 GEOGRAPHIC PRESENCE
14.15.4 PRODUCT PORTFOLIO
14.15.5 RECENT DEVELOPMENTS
14.16 INTERCEPT TELEMED
14.16.1 COMPANY OVERVIEW
14.16.2 REVENUE ANALYSIS
14.16.3 GEOGRAPHIC PRESENCE
14.16.4 PRODUCT PORTFOLIO
14.16.5 RECENT DEVELOPMENTS
14.17 KONINKLIJKE PHILIPS
14.17.1 COMPANY OVERVIEW
14.17.2 REVENUE ANALYSIS
14.17.3 GEOGRAPHIC PRESENCE
14.17.4 PRODUCT PORTFOLIO
14.17.5 RECENT DEVELOPMENTS
14.18 SOC TELEMED
14.18.1 COMPANY OVERVIEW
14.18.2 REVENUE ANALYSIS
14.18.3 GEOGRAPHIC PRESENCE
14.18.4 PRODUCT PORTFOLIO
14.18.5 RECENT DEVELOPMENTS
14.19 TELADOC HEALTH
14.19.1 COMPANY OVERVIEW
14.19.2 REVENUE ANALYSIS
14.19.3 GEOGRAPHIC PRESENCE
14.19.4 PRODUCT PORTFOLIO
14.19.5 RECENT DEVELOPMENTS
14.2 AVEL ECARE
14.20.1 COMPANY OVERVIEW
14.20.2 REVENUE ANALYSIS
14.20.3 GEOGRAPHIC PRESENCE
14.20.4 PRODUCT PORTFOLIO
14.20.5 RECENT DEVELOPMENTS
14.21 CEIBA HEALTH
14.21.1 COMPANY OVERVIEW
14.21.2 REVENUE ANALYSIS
14.21.3 GEOGRAPHIC PRESENCE
14.21.4 PRODUCT PORTFOLIO
14.21.5 RECENT DEVELOPMENTS
14.22 CLEW
14.22.1 COMPANY OVERVIEW
14.22.2 REVENUE ANALYSIS
14.22.3 GEOGRAPHIC PRESENCE
14.22.4 PRODUCT PORTFOLIO
14.22.5 RECENT DEVELOPMENTS
14.23 CLOUDPHYSICIAN
14.23.1 COMPANY OVERVIEW
14.23.2 REVENUE ANALYSIS
14.23.3 GEOGRAPHIC PRESENCE
14.23.4 PRODUCT PORTFOLIO
14.23.5 RECENT DEVELOPMENTS
14.24 CRITINEXT
14.24.1 COMPANY OVERVIEW
14.24.2 REVENUE ANALYSIS
14.24.3 GEOGRAPHIC PRESENCE
14.24.4 PRODUCT PORTFOLIO
14.24.5 RECENT DEVELOPMENTS
14.25 IMDSOFT
14.25.1 COMPANY OVERVIEW
14.25.2 REVENUE ANALYSIS
14.25.3 GEOGRAPHIC PRESENCE
14.25.4 PRODUCT PORTFOLIO
14.25.5 RECENT DEVELOPMENTS
14.26 REMOTEICU
14.26.1 COMPANY OVERVIEW
14.26.2 REVENUE ANALYSIS
14.26.3 GEOGRAPHIC PRESENCE
14.26.4 PRODUCT PORTFOLIO
14.26.5 RECENT DEVELOPMENTS
14.27 SRI LAXMI KRAVIA TECHLABS
14.27.1 COMPANY OVERVIEW
14.27.2 REVENUE ANALYSIS
14.27.3 GEOGRAPHIC PRESENCE
14.27.4 PRODUCT PORTFOLIO
14.27.5 RECENT DEVELOPMENTS
14.28 VEEONE HEALTH
14.28.1 COMPANY OVERVIEW
14.28.2 REVENUE ANALYSIS
14.28.3 GEOGRAPHIC PRESENCE
14.28.4 PRODUCT PORTFOLIO
14.28.5 RECENT DEVELOPMENTS
14.29 ENEXT ICU
14.29.1 COMPANY OVERVIEW
14.29.2 REVENUE ANALYSIS
14.29.3 GEOGRAPHIC PRESENCE
14.29.4 PRODUCT PORTFOLIO
14.29.5 RECENT DEVELOPMENTS
14.3 INOVA
14.30.1 COMPANY OVERVIEW
14.30.2 REVENUE ANALYSIS
14.30.3 GEOGRAPHIC PRESENCE
14.30.4 PRODUCT PORTFOLIO
14.30.5 RECENT DEVELOPMENTS
14.31 T-ICU
14.31.1 COMPANY OVERVIEW
14.31.2 REVENUE ANALYSIS
14.31.3 GEOGRAPHIC PRESENCE
14.31.4 PRODUCT PORTFOLIO
14.31.5 RECENT DEVELOPMENTS
14.32 GENERAL VISION INC.
14.32.1 COMPANY OVERVIEW
14.32.2 REVENUE ANALYSIS
14.32.3 GEOGRAPHIC PRESENCE
14.32.4 PRODUCT PORTFOLIO
14.32.5 RECENT DEVELOPMENTS
14.33 NVIDIA CORPORATION
14.33.1 COMPANY OVERVIEW
14.33.2 REVENUE ANALYSIS
14.33.3 GEOGRAPHIC PRESENCE
14.33.4 PRODUCT PORTFOLIO
14.33.5 RECENT DEVELOPMENTS
14.34 IBM CORPORATION
14.34.1 COMPANY OVERVIEW
14.34.2 REVENUE ANALYSIS
14.34.3 GEOGRAPHIC PRESENCE
14.34.4 PRODUCT PORTFOLIO
14.34.5 RECENT DEVELOPMENTS
14.35 AICURE
14.35.1 COMPANY OVERVIEW
14.35.2 REVENUE ANALYSIS
14.35.3 GEOGRAPHIC PRESENCE
14.35.4 PRODUCT PORTFOLIO
14.35.5 RECENT DEVELOPMENTS
14.36 ICARBONX
14.36.1 COMPANY OVERVIEW
14.36.2 REVENUE ANALYSIS
14.36.3 GEOGRAPHIC PRESENCE
14.36.4 PRODUCT PORTFOLIO
14.36.5 RECENT DEVELOPMENTS
14.37 CYRCADIA HEALTH INC.
14.37.1 COMPANY OVERVIEW
14.37.2 REVENUE ANALYSIS
14.37.3 GEOGRAPHIC PRESENCE
14.37.4 PRODUCT PORTFOLIO
14.37.5 RECENT DEVELOPMENTS
14.38 ATOMWISE, INC.
14.38.1 COMPANY OVERVIEW
14.38.2 REVENUE ANALYSIS
14.38.3 GEOGRAPHIC PRESENCE
14.38.4 PRODUCT PORTFOLIO
14.38.5 RECENT DEVELOPMENTS
14.39 PATHWAY GENOMICS CORPORATION
14.39.1 COMPANY OVERVIEW
14.39.2 REVENUE ANALYSIS
14.39.3 GEOGRAPHIC PRESENCE
14.39.4 PRODUCT PORTFOLIO
14.39.5 RECENT DEVELOPMENTS
14.4 ZEBRA MEDICAL VISION LTD.
14.40.1 COMPANY OVERVIEW
14.40.2 REVENUE ANALYSIS
14.40.3 GEOGRAPHIC PRESENCE
14.40.4 PRODUCT PORTFOLIO
14.40.5 RECENT DEVELOPMENTS
14.41 SOPHIA GENETICS
14.41.1 COMPANY OVERVIEW
14.41.2 REVENUE ANALYSIS
14.41.3 GEOGRAPHIC PRESENCE
14.41.4 PRODUCT PORTFOLIO
14.41.5 RECENT DEVELOPMENTS
14.42 APIXIO INC.
14.42.1 COMPANY OVERVIEW
14.42.2 REVENUE ANALYSIS
14.42.3 GEOGRAPHIC PRESENCE
14.42.4 PRODUCT PORTFOLIO
14.42.5 RECENT DEVELOPMENTS
14.43 MICROSOFT
14.43.1 COMPANY OVERVIEW
14.43.2 REVENUE ANALYSIS
14.43.3 GEOGRAPHIC PRESENCE
14.43.4 PRODUCT PORTFOLIO
14.43.5 RECENT DEVELOPMENTS
14.44 INTEL CORPORATION
14.44.1 COMPANY OVERVIEW
14.44.2 REVENUE ANALYSIS
14.44.3 GEOGRAPHIC PRESENCE
14.44.4 PRODUCT PORTFOLIO
14.44.5 RECENT DEVELOPMENTS
14.45 DEEPMIND TECHNOLOGIES LIMITED
14.45.1 COMPANY OVERVIEW
14.45.2 REVENUE ANALYSIS
14.45.3 GEOGRAPHIC PRESENCE
14.45.4 PRODUCT PORTFOLIO
14.45.5 RECENT DEVELOPMENTS
14.46 VIZ.AI, INC.
14.46.1 COMPANY OVERVIEW
14.46.2 REVENUE ANALYSIS
14.46.3 GEOGRAPHIC PRESENCE
14.46.4 PRODUCT PORTFOLIO
14.46.5 RECENT DEVELOPMENTS
14.47 SUBTLE MEDICAL, INC.
14.47.1 COMPANY OVERVIEW
14.47.2 REVENUE ANALYSIS
14.47.3 GEOGRAPHIC PRESENCE
14.47.4 PRODUCT PORTFOLIO
14.47.5 RECENT DEVELOPMENTS
14.48 CLOUDMEDX INC.
14.48.1 COMPANY OVERVIEW
14.48.2 REVENUE ANALYSIS
14.48.3 GEOGRAPHIC PRESENCE
14.48.4 PRODUCT PORTFOLIO
14.48.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
15 RELATED REPORTS
16 QUESTIONNAIRE
17 CONCLUSION
18 ABOUT DATA BRIDGE MARKET RESEARCH
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.